148 related articles for article (PubMed ID: 37122549)
1. Discovery of new 5-substituted-indole-2-carboxamides as dual epidermal growth factor receptor (EGFR)/cyclin dependent kinase-2 (CDK2) inhibitors with potent antiproliferative action.
Mohamed FAM; Alakilli SYM; El Azab EF; Baawad FAM; Shaaban EIA; Alrub HA; Hendawy O; Gomaa HAM; Bakr AG; Abdelrahman MH; Trembleau L; Mohammed AF; Youssif BGM
RSC Med Chem; 2023 Apr; 14(4):734-744. PubMed ID: 37122549
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and Biological Evaluation of Indole-2-Carboxamides with Potent Apoptotic Antiproliferative Activity as EGFR/CDK2 Dual Inhibitors.
Al-Wahaibi LH; Mostafa YA; Abdelrahman MH; El-Bahrawy AH; Trembleau L; Youssif BGM
Pharmaceuticals (Basel); 2022 Aug; 15(8):. PubMed ID: 36015154
[TBL] [Abstract][Full Text] [Related]
3. Design, synthesis, apoptotic, and antiproliferative effects of 5-chloro-3- (2-methoxyvinyl)-indole-2-carboxamides and pyrido[3,4-b]indol-1-ones as potent EGFR
Al-Wahaibi LH; Mohammed AF; Abdel Rahman FES; Abdelrahman MH; Gu X; Trembleau L; Youssif BGM
J Enzyme Inhib Med Chem; 2023 Dec; 38(1):2218602. PubMed ID: 37254958
[TBL] [Abstract][Full Text] [Related]
4. Design, Synthesis, and Antiproliferative Activity of New 5-Chloro-indole-2-carboxylate and Pyrrolo[3,4-
Al-Wahaibi LH; Mohammed AF; Abdelrahman MH; Trembleau L; Youssif BGM
Molecules; 2023 Jan; 28(3):. PubMed ID: 36770936
[TBL] [Abstract][Full Text] [Related]
5. New 1,2,3-Triazole/1,2,4-triazole Hybrids as Aromatase Inhibitors: Design, Synthesis, and Apoptotic Antiproliferative Activity.
Maghraby MT; Mazyad Almutairi T; Bräse S; Salem OIA; Youssif BGM; Sheha MM
Molecules; 2023 Oct; 28(20):. PubMed ID: 37894571
[TBL] [Abstract][Full Text] [Related]
6. Design and synthesis of new thiazolidinone/uracil derivatives as antiproliferative agents targeting EGFR and/or BRAF
Alshammari MB; Aly AA; Youssif BGM; Bräse S; Ahmad A; Brown AB; Ibrahim MAA; Mohamed AH
Front Chem; 2022; 10():1076383. PubMed ID: 36578355
[TBL] [Abstract][Full Text] [Related]
7. Design, Synthesis, and Biological Evaluation of Indole-2-carboxamides as Potential Multi-Target Antiproliferative Agents.
Al-Wahaibi LH; Mohammed AF; Abdelrahman MH; Trembleau L; Youssif BGM
Pharmaceuticals (Basel); 2023 Jul; 16(7):. PubMed ID: 37513950
[TBL] [Abstract][Full Text] [Related]
8. Novel piperine-carboximidamide hybrids: design, synthesis, and antiproliferative activity via a multi-targeted inhibitory pathway.
Al-Wahaibi LH; Mahmoud MA; Mostafa YA; Raslan AE; Youssif BGM
J Enzyme Inhib Med Chem; 2023 Dec; 38(1):376-386. PubMed ID: 36453023
[TBL] [Abstract][Full Text] [Related]
9. Optimization and SAR investigation of novel 2,3-dihydropyrazino[1,2-a]indole-1,4-dione derivatives as EGFR and BRAF
Gomaa HAM; Shaker ME; Alzarea SI; Hendawy OM; Mohamed FAM; Gouda AM; Ali AT; Morcoss MM; Abdelrahman MH; Trembleau L; Youssif BGM
Bioorg Chem; 2022 Mar; 120():105616. PubMed ID: 35078049
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and Structure Determination of Substituted Thiazole Derivatives as EGFR/BRAF
Al-Wahaibi LH; El-Sheref EM; Hassan AA; Bräse S; Nieger M; Youssif BGM; Ibrahim MAA; Tawfeek HN
Pharmaceuticals (Basel); 2023 Jul; 16(7):. PubMed ID: 37513926
[TBL] [Abstract][Full Text] [Related]
11. Molecular Docking and In Vitro Anticancer Screening of Synthesized Arylthiazole linked 2H-indol-2-one Derivatives as VEGFR-2 Kinase Inhibitors.
Shalmali N; Bawa S; Ali MR; Kalra S; Kumar R; Zeya B; Rizvi MA; Partap S; Husain A
Anticancer Agents Med Chem; 2022; 22(11):2166-2180. PubMed ID: 34792005
[TBL] [Abstract][Full Text] [Related]
12. Design, Synthesis and Biological Evaluation of
El-Sheref EM; Ameen MA; El-Shaieb KM; Abdel-Latif FF; Abdel-Naser AI; Brown AB; Bräse S; Fathy HM; Ahmad I; Patel H; Gomaa HAM; Youssif BGM; Mohamed AH
Molecules; 2022 Dec; 27(24):. PubMed ID: 36557897
[TBL] [Abstract][Full Text] [Related]
13. Design, synthesis, and apoptotic antiproliferative action of new 1,2,3-triazole/1,2,4-oxadiazole hybrids as dual EGFR/VEGFR-2 inhibitors.
Mahmoud MA; Mohammed AF; Salem OIA; Almutairi TM; Bräse S; Youssif BGM
J Enzyme Inhib Med Chem; 2024 Dec; 39(1):2305856. PubMed ID: 38326989
[TBL] [Abstract][Full Text] [Related]
14. Synthesis of novel spirochromane incorporating Schiff's bases, potential antiproliferative activity, and dual EGFR/HER2 inhibition: Cell cycle analysis and
Othman DIA; Hamdi A; Elhusseiny WM; El-Azab AS; Bakheit AH; Hefnawy M; Abdel-Aziz AA
Saudi Pharm J; 2023 Nov; 31(11):101803. PubMed ID: 37860686
[TBL] [Abstract][Full Text] [Related]
15. New thieno[3,2-d]pyrimidine-based derivatives: Design, synthesis and biological evaluation as antiproliferative agents, EGFR and ARO inhibitors inducing apoptosis in breast cancer cells.
Farghaly AM; AboulWafa OM; Baghdadi HH; Abd El Razik HA; Sedra SMY; Shamaa MM
Bioorg Chem; 2021 Oct; 115():105208. PubMed ID: 34365057
[TBL] [Abstract][Full Text] [Related]
16. Exploring pyrrolidinyl-spirooxindole natural products as promising platforms for the synthesis of novel spirooxindoles as EGFR/CDK2 inhibitors for halting breast cancer cells.
Nafie MS; Al-Majid AM; Ali M; Alayyaf AA; Haukka M; Ashraf S; Ul-Haq Z; El-Faham A; Barakat A
Front Chem; 2024; 12():1364378. PubMed ID: 38487783
[TBL] [Abstract][Full Text] [Related]
17. Design, Synthesis, and Anti-Proliferative Action of Purine/Pteridine-Based Derivatives as Dual Inhibitors of EGFR and BRAF
El-Kalyoubi SA; Gomaa HAM; Abdelhafez EMN; Ramadan M; Agili F; Youssif BGM
Pharmaceuticals (Basel); 2023 May; 16(5):. PubMed ID: 37242499
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of Benzamide-Chalcone Derivatives as EGFR/CDK2 Inhibitor: Synthesis, In-Vitro Inhibition, and Molecular Modeling Studies.
Joshi A; Bhojwani H; Wagal O; Begwani K; Joshi U; Sathaye S; Kanchan D
Anticancer Agents Med Chem; 2022; 22(2):328-343. PubMed ID: 33858315
[TBL] [Abstract][Full Text] [Related]
19. Design, synthesis and molecular docking of new fused 1
Belal A; Abdel Gawad NM; Mehany ABM; Abourehab MAS; Elkady H; Al-Karmalawy AA; Ismael AS
J Enzyme Inhib Med Chem; 2022 Dec; 37(1):1884-1902. PubMed ID: 35801486
[TBL] [Abstract][Full Text] [Related]
20. Discovery of new cyanopyridine/chalcone hybrids as dual inhibitors of EGFR/BRAF
Abou-Zied HA; Beshr EAM; Gomaa HAM; Mostafa YA; Youssif BGM; Hayallah AM; Abdel-Aziz M
Arch Pharm (Weinheim); 2023 Apr; 356(4):e2200464. PubMed ID: 36526595
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]